A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine–acetylcholine synaptic balance
- 1 November 2006
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (11), 974-983
- https://doi.org/10.1016/s1474-4422(06)70600-7
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneuronsNeurobiology of Disease, 2005
- M2Muscarinic Acetylcholine Receptor Knock-Out Mice Show Deficits in Behavioral Flexibility, Working Memory, and Hippocampal PlasticityJournal of Neuroscience, 2004
- Pergolide effect on cognitive functions in early-mild Parkinson?s diseaseJournal of Neural Transmission, 2004
- Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's diseaseThe Lancet Neurology, 2004
- Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learningBehavioural Brain Research, 2004
- Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant miceNature Neuroscience, 2002
- Cellular Expression of α7 Nicotinic Acetylcholine Receptor Protein in the Temporal Cortex in Alzheimer's and Parkinson's Disease— A Stereological ApproachNeurobiology of Disease, 2000
- D2 dopamine receptor gene expression by cholinergic neurons in the rat striatumNeuroscience Letters, 1990
- Cholinergic‐dependent cognitive deficits in Parkinson's diseaseAnnals of Neurology, 1987
- Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's diseaseAnnals of Neurology, 1984